DK0430287T3 - Doseringsenheder til vedvarende afgivelse af et lægemiddel - Google Patents

Doseringsenheder til vedvarende afgivelse af et lægemiddel

Info

Publication number
DK0430287T3
DK0430287T3 DK90122985.6T DK90122985T DK0430287T3 DK 0430287 T3 DK0430287 T3 DK 0430287T3 DK 90122985 T DK90122985 T DK 90122985T DK 0430287 T3 DK0430287 T3 DK 0430287T3
Authority
DK
Denmark
Prior art keywords
drug
dosage units
release
sustained
sustained release
Prior art date
Application number
DK90122985.6T
Other languages
English (en)
Other versions
DK0430287T4 (da
Inventor
Dale R Brinker
Enrique D Eveline
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27033923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0430287(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of DK0430287T3 publication Critical patent/DK0430287T3/da
Application granted granted Critical
Publication of DK0430287T4 publication Critical patent/DK0430287T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90122985T 1989-12-01 1990-11-30 Doseringsenheder til vedvarende afgivelse af et lægemiddel DK0430287T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44445889A 1989-12-01 1989-12-01
US60515290A 1990-11-02 1990-11-02

Publications (2)

Publication Number Publication Date
DK0430287T3 true DK0430287T3 (da) 1995-02-27
DK0430287T4 DK0430287T4 (da) 2000-10-02

Family

ID=27033923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90122985T DK0430287T4 (da) 1989-12-01 1990-11-30 Doseringsenheder til vedvarende afgivelse af et lægemiddel

Country Status (13)

Country Link
EP (1) EP0430287B2 (da)
JP (1) JP3010562B2 (da)
KR (1) KR100223131B1 (da)
AT (1) ATE112678T1 (da)
AU (1) AU623560B2 (da)
CA (1) CA2031150C (da)
DE (1) DE69013296T3 (da)
DK (1) DK0430287T4 (da)
ES (1) ES2065461T5 (da)
GR (1) GR3034483T3 (da)
IE (1) IE66116B1 (da)
IL (1) IL96311A (da)
PT (1) PT96046B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4127665A1 (de) * 1991-08-22 1993-02-25 Beiersdorf Ag Galenische matrix
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
JP3611456B2 (ja) 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6419953B1 (en) 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
WO2000037055A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Controlled release formulation of divalproex sodium
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
ES2308065T3 (es) * 2004-04-30 2008-12-01 Topotarget Germany Ag Formulacion que comprende un inhibidor de histona desacetilasa, que exhibe una liberacion bifasica.
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
KR100806541B1 (ko) * 2005-05-11 2008-02-26 한국유나이티드제약 주식회사 아세클로페낙을 함유하는 제어 방출성 제제
WO2009008004A2 (en) * 2007-05-23 2009-01-15 Sun Pharmaceutical Industries Limited Sustained release formulations of divalproex sodium
EP2030613A1 (en) * 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963451A (en) † 1973-02-15 1976-06-15 United States Steel Corporation Method of forming a high-temperature abrasion-resistant coating on a ferrous metal substrate, and resulting article
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
FI63335B (fi) † 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
DK150008C (da) † 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
GB2186485B (en) † 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom

Also Published As

Publication number Publication date
DE69013296T3 (de) 2000-11-09
DE69013296D1 (de) 1994-11-17
EP0430287A3 (en) 1991-08-21
KR100223131B1 (ko) 1999-10-15
CA2031150C (en) 2000-11-21
IE66116B1 (en) 1995-12-13
IL96311A0 (en) 1991-08-16
AU6764390A (en) 1991-02-14
GR3034483T3 (en) 2000-12-29
ES2065461T3 (es) 1995-02-16
EP0430287B2 (en) 2000-07-12
JP3010562B2 (ja) 2000-02-21
IE904091A1 (en) 1991-06-05
EP0430287A2 (en) 1991-06-05
AU623560B2 (en) 1992-05-14
IL96311A (en) 1995-05-26
PT96046A (pt) 1991-09-13
DE69013296T2 (de) 1995-02-23
PT96046B (pt) 2001-09-27
DK0430287T4 (da) 2000-10-02
JPH03190817A (ja) 1991-08-20
ES2065461T5 (es) 2001-01-01
KR910011243A (ko) 1991-08-07
CA2031150A1 (en) 1991-06-02
ATE112678T1 (de) 1994-10-15
EP0430287B1 (en) 1994-10-12

Similar Documents

Publication Publication Date Title
DK0430287T3 (da) Doseringsenheder til vedvarende afgivelse af et lægemiddel
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
DE59202537D1 (de) Feste pharmazeutische Retardform.
ATE202473T1 (de) Rasch freisetzende tablettenkerne mit unlöslichen arzneistoffen und mit einem retardüberzug
DE60103186D1 (de) Stossweise freisetzende Arzneiabgabesysteme
BR9608785A (pt) Forma de dosagem oral contendo como um princípio ativo um ácido mega-3- poli insaturado uso de um ácido ómega-3-poli insaturado e processo de tratar inflamação intestinal
FR2655266B1 (fr) Compositions pharmaceutiques a base de cimetidine.
KR880010759A (ko) 방출 조절성 제제
KR860002271A (ko) 조절되게 방출되게끔(controlled-release) 코오팅된 조제학상의 제제와 그 제제의 제조방법
FI904888A0 (fi) Foerfarande foer framstaellning av ett oestrogenhaltigt medikamentplaoster.
DE3853853D1 (de) Verabreichungsformen für Pharmaka.
AU7534087A (en) Sustained release pharmaceutical compositions in oral dosage form
KR870000069A (ko) 안정한 고체 제형의 제조 방법
KR890700344A (ko) 약학 제제
KR880010758A (ko) 서방성 제제
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
SE8803822D0 (sv) Novel dosage form
HK126193A (en) Drug particles having constant release
DE69307807D1 (de) Naproxen-Tabletten mit gesteuerter Wirkstoffabgabe
ITMI942483A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
JPS57183714A (en) Medicinal pharmaceutical
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten